The Gleason score is a microscopic grading system for prostate adenocarcinoma that describes how abnormal and disorganized the cancer’s glandular architecture looks compared with normal prostate tissue. A pathologist identifies the dominant cancer growth patterns in biopsy or prostate-removal tissue, assigns Gleason pattern grades, and combines two patterns into a score. In contemporary practice, prostate cancer is usually reported from Gleason score 6 through 10 and translated into an ISUP Grade Group from 1 through 5. Higher Gleason patterns and higher Grade Groups generally indicate more aggressive cancer biology, but grade does not by itself determine stage, prognosis or treatment.
The Gleason score is usually written as two numbers—for example 3+4=7 or 4+3=7. Those numbers describe microscopic growth patterns, not separate tumors and not percentages. The order matters: 3+4 and 4+3 both total 7, but 4+3 contains more higher-grade pattern 4 architecture and is therefore assigned a higher Grade Group. The score becomes clinically useful only when combined with PSA, biopsy extent, MRI findings and cancer stage.
How Is a Gleason Score Determined From Prostate Cancer Tissue?
The score begins with tissue, not with PSA or imaging
A Gleason score cannot be calculated from:
- PSA;
- digital rectal examination;
- prostate MRI;
- PI-RADS;
- or TRUS.
It requires prostate tissue.
That tissue usually comes from a prostate biopsy, although grading can also be performed on tissue removed during surgery.
What does the pathologist actually examine?
Under the microscope, normal prostate tissue is made of organized glands with recognizable architecture.
Prostate adenocarcinoma progressively loses that organization as grade increases.
The pathologist evaluates:
- how individual glands are formed;
- whether malignant glands remain separate or become fused;
- whether cribriform structures are present;
- whether recognizable gland formation is lost;
- and how cancer infiltrates surrounding prostate tissue.
What are Gleason patterns 1 through 5?
The original Gleason system included patterns 1 through 5.
Contemporary prostate-cancer pathology has changed substantially.
Patterns 1 and 2 are essentially not assigned to prostate cancer on modern needle biopsy.
Most clinically diagnosed prostate adenocarcinoma is therefore graded using:
- Pattern 3;
- Pattern 4;
- Pattern 5.
What does Gleason pattern 3 look like?
Pattern 3 cancer forms individual malignant glands that remain recognizably separate.
The glands infiltrate prostate tissue but retain gland formation.
This is the lowest pattern used in modern clinically diagnosed prostate adenocarcinoma.
What does Gleason pattern 4 look like?
Pattern 4 represents a greater loss of normal glandular architecture.
It can include:
- fused glands;
- poorly formed glands;
- glomeruloid architecture;
- and cribriform architecture.
The transition from pattern 3 to pattern 4 is clinically important because even a component of pattern 4 can move a cancer from Grade Group 1 into Grade Group 2 or higher.
What does Gleason pattern 5 look like?
Pattern 5 shows the greatest loss of recognizable gland formation.
It can include:
- solid sheets of malignant cells;
- cords;
- single infiltrating cells;
- or comedonecrosis within malignant architecture.
Pattern 5 is associated with high-grade disease.
Why are two pattern numbers added together?
Prostate cancer is often heterogeneous.
One biopsy core or one tumor focus can contain more than one architectural pattern.
The Gleason score therefore combines two patterns rather than pretending the cancer has only one appearance.
What does the first number mean?
Traditionally, the first number is the primary pattern—the pattern occupying the greatest amount of cancer in the assessed tissue.
For example:
3+4=7
means pattern 3 is predominant and pattern 4 is present as a lesser component.
What does the second number mean?
The second component captures additional higher-grade architecture that is clinically important.
Modern biopsy grading deliberately incorporates adverse higher-grade patterns rather than allowing a small aggressive component to disappear from the score.
Why does 3+4 differ from 4+3?
Because the order reflects which architecture predominates.
A 3+4 cancer contains more pattern 3 than pattern 4.
A 4+3 cancer contains more pattern 4 than pattern 3.
Pattern 4 is biologically less favorable than pattern 3.
Therefore:
- 3+4=7 → Grade Group 2;
- 4+3=7 → Grade Group 3.
The Gleason score is not ordinary arithmetic. Although 3+4 and 4+3 both equal 7 mathematically, prostate pathology treats them differently because the order records which growth pattern dominates. That distinction is one reason the modern Grade Group system was created.
What Do Gleason Scores 6, 7, 8, 9 and 10 Mean?
Modern prostate cancer generally starts at Gleason 6
Patients are often confused when told that a Gleason score of 6 is the “lowest grade” prostate cancer even though the scale appears to begin at 2.
The explanation is historical.
The original Gleason classification allowed scores as low as 2.
Contemporary pathology definitions reclassified many patterns previously called 1 or 2.
As a result, Gleason 3+3=6 is effectively the lowest score assigned to ordinary prostate adenocarcinoma on modern needle biopsy.
What does Gleason 3+3=6 mean?
Gleason 3+3=6 means that the sampled cancer is composed of pattern 3 architecture without identified pattern 4 or 5 in the graded tissue.
It corresponds to:
ISUP Grade Group 1.
When other features are also favorable, Grade Group 1 cancer often falls into a low-risk clinical category and may be appropriate for active surveillance rather than immediate treatment.
That does not mean:
- the diagnosis is “not cancer”;
- follow-up is unnecessary;
- the entire prostate has been sampled;
- or progression is impossible.
What does Gleason 3+4=7 mean?
Gleason 3+4 means the tumor is predominantly pattern 3 but contains some pattern 4.
It corresponds to:
Grade Group 2.
The amount of pattern 4 matters.
A biopsy containing:
- 5% pattern 4;
- 20% pattern 4;
- or 45% pattern 4
can all technically fall within 3+4, yet they do not necessarily carry identical biological risk.
This is why modern pathology reports often state the percentage of pattern 4.
Can some Grade Group 2 cancers still be managed with active surveillance?
Yes, in carefully selected patients.
Selected men with favorable localized Grade Group 2 cancer may be considered for active surveillance depending on factors such as:
- low PSA and PSA density;
- small amount of pattern 4;
- limited cancer volume;
- favorable MRI findings;
- absence of adverse histological architecture;
- age and health;
- and patient preferences.
Grade Group 2 should therefore not automatically be translated into “must treat immediately.”
What does Gleason 4+3=7 mean?
Gleason 4+3 means pattern 4 predominates over pattern 3.
It corresponds to:
Grade Group 3.
Compared with 3+4, it generally indicates:
- greater architectural aggressiveness;
- higher recurrence risk;
- and a stronger likelihood that definitive treatment and staging considerations will enter the discussion.
What does Gleason score 8 mean?
Gleason score 8 corresponds to Grade Group 4.
Possible combinations include:
- 4+4=8;
- 3+5=8;
- 5+3=8.
These combinations all enter Grade Group 4, but the underlying pattern composition still provides useful pathological information.
What do Gleason scores 9 and 10 mean?
Gleason 9–10 correspond to:
Grade Group 5.
Common combinations include:
- 4+5=9;
- 5+4=9;
- 5+5=10.
These cancers contain substantial pattern 5 or exclusively pattern 5 architecture and are considered high-grade disease.
Why was the Grade Group system introduced?
The Grade Group system makes the biological hierarchy easier to understand.
A patient hearing “Gleason 6 out of 10” may incorrectly assume that the cancer sits in the middle of a 1-to-10 severity scale.
Grade Group 1 communicates more clearly that Gleason 3+3 is the lowest contemporary grade category.
Is Grade Group replacing the Gleason score?
Not completely.
Modern pathology reports commonly include both.
For example:
Gleason score 3+4=7, ISUP Grade Group 2.
The next article explains this translation in detail and why both systems may appear on the same pathology report.
What is percentage pattern 4?
When cancer is Gleason 3+4 or 4+3, the amount of pattern 4 can add useful information.
Current European pathology recommendations support reporting the percentage of pattern 4 in Gleason score 7 disease.
This helps distinguish:
- a tumor with only a very small pattern 4 component;
- from one approaching a pattern 4 majority.
What is cribriform prostate cancer?
Cribriform architecture is a subtype of pattern 4 in which malignant glands form larger sieve-like structures containing multiple luminal spaces.
It is clinically important because cribriform growth is associated with less favorable outcomes compared with some other pattern 4 architectures.
Modern pathology reports increasingly document whether invasive cribriform carcinoma is present.
What is intraductal carcinoma of the prostate?
Intraductal carcinoma of the prostate, often abbreviated IDC-P, is an adverse pathological finding in which malignant-appearing cells extensively involve existing prostate ducts or glands while retaining parts of the native ductal framework.
IDC-P is associated with aggressive disease and is generally reported separately because of its prognostic importance.
Two cancers with the same Grade Group are not always biologically identical. Percentage pattern 4, cribriform architecture, intraductal carcinoma, amount of cancer in biopsy cores, PSA and stage all add information beyond the headline Gleason score.
How Does Gleason Score Affect Prostate Cancer Risk, Prognosis and Management?
Higher grade generally means greater biological aggressiveness
As Gleason pattern and Grade Group increase, prostate cancer is generally more likely to:
- grow more rapidly;
- extend outside the prostate;
- involve regional lymph nodes;
- recur after local treatment;
- or eventually metastasize.
That is why grade is one of the central variables used in prostate-cancer risk classification.
Does Gleason score tell whether the cancer has spread?
No.
This is one of the most important distinctions in prostate cancer.
Grade describes what the cancer looks like under the microscope.
Stage describes where the cancer is in the body.
A Grade Group 5 cancer may still be anatomically localized at diagnosis.
A lower-grade cancer may occasionally have a larger local extent than expected.
Grade and stage are related statistically but are not interchangeable.
What else determines prostate cancer risk besides Gleason score?
Clinicians commonly combine grade with:
- PSA;
- clinical T stage;
- MRI findings;
- number of positive biopsy cores;
- amount of cancer within each core;
- PSA density;
- adverse pathology such as cribriform or intraductal carcinoma;
- lymph-node or metastatic findings when staging imaging is indicated;
- and selected genomic or molecular information in specific clinical settings.
How does Grade Group affect treatment discussions?
Grade Group helps determine how urgently clinicians need to consider:
- active surveillance;
- curative-intent local treatment;
- additional staging imaging;
- radiation combined with androgen-deprivation therapy in selected risk groups;
- or systemic treatment for advanced disease.
The Grade Group alone does not choose the treatment.
What usually happens with Grade Group 1?
For appropriately selected localized disease, Grade Group 1 is commonly managed with active surveillance rather than immediate surgery or radiation.
Surveillance typically relies on a structured combination of:
- PSA monitoring;
- clinical follow-up;
- MRI;
- and repeat tissue assessment when indicated.
What usually happens with Grade Group 2?
Grade Group 2 occupies a wider clinical spectrum.
Selected favorable cases may remain candidates for surveillance.
Other Grade Group 2 cancers are better managed with definitive treatment because of:
- larger pattern 4 component;
- greater biopsy tumor volume;
- adverse MRI findings;
- unfavorable PSA characteristics;
- or adverse histological architecture.
What does Grade Group 3 usually imply?
Grade Group 3 generally carries greater progression and recurrence risk than Grade Group 2 because pattern 4 predominates.
It is less commonly considered suitable for surveillance and more often triggers discussion of definitive therapy and appropriate staging.
What do Grade Groups 4 and 5 imply?
These are high-grade cancers.
They generally increase concern for:
- extraprostatic extension;
- lymph-node involvement;
- metastatic disease;
- biochemical recurrence;
- and prostate-cancer mortality.
Depending on PSA, stage and clinical context, additional staging imaging may be appropriate before treatment planning.
Does a higher Gleason score mean treatment cannot cure the cancer?
No.
High-grade cancer can still be localized or regionally confined at diagnosis.
Selected men with high-risk localized disease may receive curative-intent treatment.
The presence of Grade Group 4 or 5 therefore means the biology is more aggressive—not that cure is automatically impossible.
Does Gleason score predict survival exactly?
No.
It contributes strongly to prognosis at the population level, but an individual man’s outcome depends on the complete disease state.
Two patients with identical Grade Group can have very different:
- PSA values;
- tumor volumes;
- MRI findings;
- stages;
- health conditions;
- and treatment options.
A high Gleason score should not be interpreted without stage. Grade Group 5 localized prostate cancer and Grade Group 5 metastatic prostate cancer share aggressive histology, but they represent very different anatomical disease states and require different management discussions.
Can the Gleason Score Change After Surgery, Repeat Biopsy or Pathology Review?
Yes—because biopsy samples only part of the prostate
A prostate biopsy removes thin tissue cores from selected regions.
Even a carefully performed MRI-targeted biopsy cannot examine every cancer cell within the gland.
Prostate cancer can also be heterogeneous.
Different areas may contain:
- pattern 3;
- pattern 4;
- pattern 5;
- or different combinations of those patterns.
What is Gleason upgrading?
Upgrading means a later specimen shows a higher grade than the original biopsy.
For example:
biopsy: Gleason 3+3=6 / Grade Group 1
followed by:
prostatectomy: Gleason 3+4=7 / Grade Group 2.
This usually means the original biopsy did not sample or did not contain the higher-grade component that was present elsewhere in the prostate.
What is downgrading?
Downgrading means the larger or later specimen is assigned a lower grade than the earlier sample.
This can occur because:
- a biopsy happened to sample a small high-grade focus;
- the relative pattern proportions differ in the larger specimen;
- or expert pathology review changes interpretation.
Does MRI reduce upgrading?
MRI-targeted biopsy improves sampling of the dominant suspicious lesion and can improve grade characterization compared with systematic sampling alone.
However, it does not completely eliminate upgrading because:
- MRI can underestimate tumor extent;
- small higher-grade foci may be MRI-invisible;
- needle placement is not perfectly exact;
- and separate tumor foci can exist elsewhere in the gland.
Can different biopsy cores have different Gleason scores?
Yes.
One core may show:
3+3=6
while another shows:
3+4=7
and an MRI target may show:
4+3=7.
This reflects real intraprostatic heterogeneity.
How are multiple targeted cores from one MRI lesion handled?
Pathology reporting can group or aggregate cores obtained from the same MRI target so the grade reflects the lesion as a clinically meaningful unit.
The exact reporting method depends on laboratory practice and current pathological standards.
Should pathology be reviewed before major treatment?
Expert pathology review can be valuable when:
- the diagnosis is unusual;
- pattern 3 versus pattern 4 is borderline;
- cribriform or intraductal architecture is uncertain;
- the grade is unexpectedly high or low compared with imaging;
- or treatment decisions depend heavily on a small pattern difference.
Can inflammation be mistaken for cancer grade?
Inflammation itself does not receive a Gleason score.
The score applies to prostate adenocarcinoma.
A pathologist first determines whether malignant glands are present and only then grades the cancer.
What does “ASAP” mean on a pathology report?
Atypical small acinar proliferation, often abbreviated ASAP, means the pathologist sees a suspicious small focus but does not have enough evidence to make a definitive cancer diagnosis.
ASAP is not a Gleason score.
It is an indeterminate pathological finding that may prompt further evaluation depending on the clinical context.
What does high-grade PIN mean?
High-grade prostatic intraepithelial neoplasia is an abnormal epithelial change associated with prostate carcinogenesis but is not the same as invasive prostate adenocarcinoma.
It therefore does not receive a Gleason score.
What happens once the Grade Group is known?
The pathology result is combined with:
- PSA;
- MRI;
- clinical examination;
- tumor extent in cores;
- and appropriate staging information
to classify the disease more completely.
This transition from suspicion to tissue diagnosis is explained in How Prostate Cancer Is Diagnosed.
The biopsy Gleason score is a sample-based estimate of cancer grade. It is highly important, but it should be interpreted alongside how the biopsy was performed, how much cancer was sampled, which MRI lesion was targeted and whether the findings are concordant with PSA and imaging.
Gleason Score and Grade Group Reference Table
| Gleason score | Grade Group | Microscopic interpretation | General clinical significance |
|---|---|---|---|
| 3+3=6 | 1 | Pattern 3 architecture only in the graded cancer. | Lowest contemporary grade category; many localized cases are suitable for active-surveillance assessment. |
| 3+4=7 | 2 | Pattern 3 predominates with a lesser component of pattern 4. | Intermediate biology; percentage pattern 4 and other risk factors strongly affect management. |
| 4+3=7 | 3 | Pattern 4 predominates over pattern 3. | Higher risk than 3+4 despite identical Gleason total. |
| 4+4=8 | 4 | Pattern 4 architecture without lower-grade predominance. | High-grade cancer; staging and definitive-treatment evaluation commonly become important. |
| 3+5=8 | 4 | Predominantly pattern 3 with a clinically important pattern 5 component. | High-grade disease because pattern 5 is present. |
| 5+3=8 | 4 | Pattern 5 predominates with secondary pattern 3. | High-grade disease. |
| 4+5=9 | 5 | Pattern 4 predominates with secondary pattern 5. | Very high-grade cancer. |
| 5+4=9 | 5 | Pattern 5 predominates. | Very high-grade cancer with substantial pattern 5 architecture. |
| 5+5=10 | 5 | Pattern 5 architecture in both graded components. | Highest Gleason score and highest Grade Group. |
Common Questions About Gleason Score
| Question | Practical answer |
|---|---|
| What is the Gleason score? | A histological grading system that describes the microscopic glandular architecture of prostate adenocarcinoma. |
| How is Gleason score measured? | A pathologist examines prostate tissue under a microscope, identifies cancer growth patterns and combines two pattern grades. |
| Can PSA tell my Gleason score? | No. PSA is a blood biomarker and cannot determine microscopic cancer grade. |
| Can MRI tell my Gleason score? | No. MRI can estimate lesion suspicion but cannot reliably assign the pathology Grade Group. |
| Can TRUS determine Gleason score? | No. TRUS shows anatomy and can guide biopsy, but grading requires pathology. |
| Why does modern Gleason scoring start at 6? | Patterns historically called 1 and 2 are no longer used for ordinary prostate cancer diagnosis on modern needle biopsy, making 3+3=6 the lowest contemporary score. |
| Is Gleason 6 low-grade prostate cancer? | Yes. Gleason 3+3=6 corresponds to Grade Group 1, the lowest modern grade category. |
| Does Gleason 6 mean the cancer is harmless? | No. It is cancer and requires appropriate follow-up, although many localized Grade Group 1 cancers can be safely managed with active surveillance. |
| What does Gleason 7 mean? | It can mean either 3+4=7, Grade Group 2, or 4+3=7, Grade Group 3. Those are not biologically equivalent. |
| Is 4+3 worse than 3+4? | In general, yes. Pattern 4 predominates in 4+3, giving it a higher Grade Group and less favorable prognosis. |
| What does Gleason 8 mean? | Gleason 8 corresponds to Grade Group 4 and is considered high-grade prostate cancer. |
| What does Gleason 9 mean? | Gleason 9 corresponds to Grade Group 5 and contains pattern 5 cancer architecture. |
| What does Gleason 10 mean? | Gleason 5+5=10 is the highest Gleason score and belongs to Grade Group 5. |
| Is Gleason score the same as Grade Group? | No. Grade Group is a modern 1-to-5 category derived from the Gleason pattern combination. |
| What is Grade Group 1? | Gleason 3+3=6. |
| What is Grade Group 2? | Gleason 3+4=7. |
| What is Grade Group 3? | Gleason 4+3=7. |
| What is Grade Group 4? | Gleason score 8. |
| What is Grade Group 5? | Gleason score 9–10. |
| What is Gleason pattern 3? | Malignant prostate glands remain individually formed despite infiltrating surrounding tissue. |
| What is Gleason pattern 4? | More disorganized cancer architecture including fused, poorly formed, glomeruloid or cribriform glands. |
| What is Gleason pattern 5? | High-grade cancer with little or no recognizable gland formation, including solid sheets, cords or single-cell growth. |
| What is percentage pattern 4? | The proportion of cancer composed of pattern 4 in a Gleason 7 tumor; it adds detail beyond the 3+4 or 4+3 label. |
| What is cribriform prostate cancer? | A pattern 4 architecture with larger malignant glandular structures containing multiple luminal spaces; it is considered an adverse pathological feature. |
| What is intraductal carcinoma? | An adverse pathological finding involving malignant cells expanding existing prostate ducts and glands; it is reported because of its association with aggressive disease. |
| Does Gleason score tell whether cancer has spread? | No. Grade and stage are different. Grade describes microscopic biology; stage describes anatomical extent. |
| Can Gleason score change after surgery? | Yes. A larger prostatectomy specimen may reveal higher- or lower-grade architecture than the biopsy sampled. |
| What is Gleason upgrading? | A later specimen shows a higher Grade Group than the initial biopsy. |
| What is Gleason downgrading? | A later or expert-reviewed specimen shows a lower grade than the earlier assessment. |
| Why can biopsy underestimate grade? | Needle biopsy samples only a small fraction of the prostate and may miss a higher-grade component elsewhere. |
| Does MRI-targeted biopsy reduce grading error? | It improves sampling of suspicious lesions but cannot eliminate tumor heterogeneity or microscopic disease outside the target. |
| Can different biopsy cores have different Grade Groups? | Yes. Prostate cancer can contain several different architectural patterns in different locations. |
| Can Grade Group 1 be watched instead of treated? | Yes. Active surveillance is a standard option for many appropriately selected men with localized low-risk Grade Group 1 disease. |
| Can Grade Group 2 be watched? | Selected favorable Grade Group 2 cancers may be considered for surveillance depending on pattern 4 amount, cancer volume, PSA, MRI and other risk features. |
| Does Grade Group 5 mean metastatic cancer? | No. Grade Group 5 is very high-grade histology but can still be anatomically localized when diagnosed. |
| What other information is needed after Gleason score? | PSA, cancer volume in biopsy cores, MRI, clinical stage and appropriate staging imaging are combined to determine the overall disease state. |
Key Clinical Takeaways
- The Gleason score is a microscopic grading system for prostate adenocarcinoma.
- It describes glandular architecture rather than tumor size or anatomical spread.
- The score requires tissue from biopsy or surgery.
- PSA cannot determine Gleason score.
- MRI cannot determine Gleason score.
- TRUS cannot determine Gleason score.
- Contemporary pathology primarily uses Gleason patterns 3, 4 and 5.
- Patterns 1 and 2 are essentially not assigned on modern prostate needle biopsy.
- Pattern 3 retains separate malignant gland formation.
- Pattern 4 includes fused, poorly formed, glomeruloid and cribriform architecture.
- Pattern 5 shows little or no recognizable gland formation.
- Gleason score combines two important patterns.
- 3+3=6 corresponds to Grade Group 1.
- 3+4=7 corresponds to Grade Group 2.
- 4+3=7 corresponds to Grade Group 3.
- Gleason score 8 corresponds to Grade Group 4.
- Gleason scores 9–10 correspond to Grade Group 5.
- 3+4 and 4+3 are not biologically equivalent despite both totaling 7.
- 4+3 is higher risk because pattern 4 predominates.
- Percentage pattern 4 adds prognostic detail within Gleason 7 cancers.
- Cribriform architecture is an adverse pattern 4 feature.
- Intraductal carcinoma is also an important adverse pathological finding.
- Grade Group was introduced partly to make the Gleason hierarchy easier for patients and clinicians to understand.
- Gleason 6 is the lowest ordinary contemporary prostate-cancer score, not the middle of a meaningful 1-to-10 scale.
- Grade describes biological appearance under the microscope.
- Stage describes where cancer has spread anatomically.
- Grade and stage must not be treated as the same thing.
- A Grade Group 5 cancer can still be localized.
- Gleason score is a major predictor of recurrence and progression risk.
- Higher Grade Groups are generally associated with less favorable prognosis.
- Grade alone does not determine an individual patient’s outcome.
- PSA, stage, MRI and amount of cancer in biopsy cores materially change risk interpretation.
- Many localized Grade Group 1 cancers can be managed with active surveillance.
- Selected favorable Grade Group 2 cancers can also be considered for surveillance.
- Grade Group 3 generally carries greater progression risk than Grade Group 2.
- Grade Groups 4 and 5 are high-grade disease and often prompt broader staging and treatment evaluation.
- High-grade disease does not automatically mean cure is impossible.
- Biopsy Gleason score can differ from the final prostatectomy score.
- Upgrading occurs when later tissue shows a higher grade.
- Downgrading occurs when later tissue shows a lower grade.
- Sampling error and true tumor heterogeneity both contribute to grading differences.
- MRI-targeted biopsy improves grade sampling but cannot eliminate under-sampling.
- Different biopsy cores can contain different Grade Groups.
- ASAP is not a Gleason score and does not itself equal prostate cancer.
- High-grade PIN is not invasive prostate cancer and does not receive a Gleason score.
- Once grade is established, it must be integrated with PSA, MRI, stage and clinical context before management is chosen.
Clinical bottom line: the Gleason score describes what prostate adenocarcinoma looks like under the microscope and how much normal glandular architecture the cancer has lost. Contemporary grading begins with patterns 3, 4 and 5 and converts their combination into Grade Groups 1 through 5. The distinction between 3+4 and 4+3 is especially important because pattern 4 carries greater biological risk. Higher grade generally predicts a greater chance of progression, recurrence and spread, but Gleason score is only one dimension of the disease. PSA, amount of cancer in biopsy cores, MRI findings and anatomical stage determine whether a specific cancer is suitable for surveillance, localized treatment or broader staging and systemic-treatment evaluation.
Medical disclaimer: This article provides general medical education about prostate-cancer grading. A Gleason score must be interpreted from an actual pathology report and in the context of PSA, biopsy extent, MRI findings, clinical stage, overall health and other pathological features. Do not make treatment decisions from the Gleason total alone.
The Gleason score becomes available only after tissue has been examined. For how that tissue is obtained, see What Is a Prostate Biopsy? and MRI-Targeted Prostate Biopsy. For the imaging used during many biopsy procedures, see Prostate Ultrasound (TRUS). For the pathway that combines PSA, examination, MRI and pathology, see How Prostate Cancer Is Diagnosed. For the imaging findings that commonly precede biopsy, review Prostate MRI, PI-RADS and Prostate Lesions. For the biochemical side of risk assessment, see PSA Testing and PSA Density. For the broader disease pathway, return to the Prostate Cancer hub. The next guide explains Gleason score versus Grade Group, including exactly how Gleason 6–10 translates into Grade Groups 1–5 and why 3+4 differs from 4+3.
Evidence Sources
- European Association of Urology — Prostate Cancer Classification and Staging: contemporary Gleason grading, ISUP Grade Groups and the distinction between grade and stage.
- European Association of Urology — Diagnostic Evaluation: biopsy pathology reporting, percentage pattern 4, cribriform carcinoma, intraductal carcinoma, biopsy sampling and MRI-targeted tissue assessment.
- National Cancer Institute — Prostate Cancer Treatment PDQ for patients: Gleason scoring, Grade Groups, risk classification and treatment context.
- National Cancer Institute — Prostate Cancer Treatment, Health Professional Version: histological grading, prognosis, stage and treatment considerations.
- American Cancer Society — Prostate Cancer Stages and Grade Groups: clinical explanation of Gleason scores, Grade Groups and staging.
- College of American Pathologists — Cancer Protocol Templates: standardized pathological reporting frameworks for prostate specimens.
